Lyra Therapeutics, Inc. (LYRA) Insider Trading

Name: Lyra Therapeutics, Inc. (LYRA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (May 15, 2026): W. Bradford Smith (Director): Disposition to Issuer of 640 shares.

Get alerted when insiders trade LYRA

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta